{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:15:44Z","timestamp":1790158544766,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-34300"],"award-info":[{"award-number":["HL-34300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.prostaglandins.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T17:32:44Z","timestamp":1462987964000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females"],"prefix":"10.1016","volume":"123","author":[{"given":"Stephen J.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gotlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"O\u2019Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0005","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/oby.20851","article-title":"Duration of obesity and overweight and risk of type 2 diabetes among us women","volume":"22","author":"Hu","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000052314.95497.78","article-title":"The kidney, hypertension, and obesity","volume":"41","author":"Hall","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0015","doi-asserted-by":"crossref","first-page":"R1241","DOI":"10.1152\/ajpregu.00292.2012","article-title":"Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity","volume":"303","author":"Hall","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0020","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/CIRCULATIONAHA.112.000769","article-title":"Quantifying options for reducing coronary heart disease mortality by 2020","volume":"127","author":"Huffman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ahj.2013.12.009","article-title":"The association between body mass index and coronary artery disease severity: a comparison of black and white patients","volume":"167","author":"Stalls","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.111.077487","volume":"127","author":"Purnell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0035","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0040","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/oby.20224","article-title":"Severe obesity, heart disease, and death among White, African American, and Hispanic postmenopausal women","volume":"22","author":"Mctigue","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.fertnstert.2008.08.016","article-title":"Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome","volume":"92","author":"Kaya","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0050","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1074\/jbc.M411863200","article-title":"The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species","volume":"280","author":"Lin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.RES.0000091828.36599.34","article-title":"Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells","volume":"93","author":"Abraham","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0060","doi-asserted-by":"crossref","first-page":"H2468","DOI":"10.1152\/ajpheart.01187.2003","article-title":"Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes","volume":"287","author":"Abraham","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0092-8674(81)90039-8","article-title":"Hemin enhances the differentiation of mouse 3t3cells to adipocytes","volume":"26","author":"Chen","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0070","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1210\/en.2009-0800","article-title":"Regulation of adipogenesis by natural and synthetic Rev-Erb ligands","volume":"151","author":"Kumar","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"October (26)","key":"10.1016\/j.prostaglandins.2016.04.004_bib0080","article-title":"Translational significance of heme oxygenase in obesity and metabolic syndrome","author":"Abraham","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","article-title":"Local adipose tissue renin-angiotensin system","volume":"10","author":"Cassis","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0090","doi-asserted-by":"crossref","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","article-title":"Activation of the systemic and adipose renin-angiotensin system In rats with diet-induced obesity and hypertension","volume":"287","author":"Boustany","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1124\/jpet.106.107482","article-title":"Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects","volume":"319","author":"Kruger","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2210-4-26","article-title":"Peroxynitrite-mediated inactivation of heme oxygenases","volume":"4","author":"Kinobe","year":"2004","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0105","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/oby.20559","article-title":"Increased Ho-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of Fgf21","volume":"22","author":"Hinds","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/HYPERTENSIONAHA.115.06040","article-title":"Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice","volume":"66","author":"Yiannikouris","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00431-012-1873-7","article-title":"Gender-specific prevalence and associated risk factors of prehypertension among rural children and adolescents in Northeast China: a cross-sectional study","volume":"172","author":"Guo","year":"2013","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0120","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1152\/ajpregu.00323.2011","article-title":"Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice","volume":"302","author":"Yiannikouris","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.0000136808.72912.D9","article-title":"Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans","volume":"110","author":"Ward","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2008.10.028","article-title":"20-Hete and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction","volume":"46","author":"Tsai","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0135","doi-asserted-by":"crossref","first-page":"C448","DOI":"10.1152\/ajpcell.1989.256.2.C448","article-title":"Angiotensinogen gene expression in 3t3-L1 cells","volume":"256","author":"Saye","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/en.2003-0767","article-title":"Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes","volume":"145","author":"Cassis","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1194\/jlr.M033894","article-title":"Cyclooxygenase-2 dependent metabolism of 20-Hete increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes","volume":"54","author":"Kim","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0150","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/ATVBAHA.112.248344","article-title":"Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction","volume":"32","author":"Cheng","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0155","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/HYPERTENSIONAHA.110.154559","article-title":"Cyp4a2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent","volume":"56","author":"Sodhi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.CIR.0000046269.52392.14","article-title":"Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension","volume":"107","author":"Laffer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.HYP.0000112224.87290.3a","article-title":"20-Hete and circulating insulin In essential hypertension with obesity","volume":"43","author":"Laffer","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1681\/ASN.2013090980","article-title":"Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy","volume":"26","author":"Gangadhariah","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000337591","article-title":"Heme oxygenase (Ho-1) rescue of adipocyte dysfunction in Ho-2 deficient mice via recruitment of epoxyeicosatrienoic acids (Eets) and adiponectin","volume":"29","author":"Burgess","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0180","doi-asserted-by":"crossref","first-page":"F731","DOI":"10.1152\/ajprenal.00188.2015","article-title":"Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin","volume":"309","author":"Munusamy","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0185","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1152\/ajpregu.00039.2015","article-title":"Angiotensin II receptor blockade or deletion of vascular endothelial ace does not prevent vascular dysfunction and remodeling in 20-Hete-dependent hypertension","volume":"309","author":"Garcia","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-Hete and blood pressure regulation: clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0195","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1194\/jlr.M800610-JLR200","article-title":"The L-4f mimetic peptide prevents insulin resistance through increased levels of Ho-1, pampk, and pakt in obese mice","volume":"50","author":"Peterson","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0200","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.110.151423","article-title":"Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice","volume":"56","author":"Burgess","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"Luscher","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0268-960X(91)90004-V","article-title":"Molecular regulation? Biological role of heme in hematopoiesis","volume":"5","author":"Abraham","year":"1991","journal-title":"Blood Rev."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4613-0623-8_13","article-title":"Cytochrome P450 dependent arachidonic acid metabolism in hemopoietic cells","volume":"271","author":"Lutton","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0220","first-page":"87","article-title":"Development of a cytochrome P-450 monooxygenase system in clonogenic hemopoietic cells","volume":"56","author":"Lutton","year":"1987","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0225","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood.V78.6.1461.1461","article-title":"Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid","volume":"78","author":"Abraham","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0230","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1016\/S0021-9258(18)53107-0","article-title":"Regulation of adipocyte gene expression in differentiation and syndromes of obesity\/diabetes","volume":"268","author":"Spiegelman","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0235","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/physrev.1998.78.3.783","article-title":"Understanding adipocyte differentiation","volume":"78","author":"Gregoire","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0240","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1101\/gad.6.4.533","article-title":"Antisense CCAAT\/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3t3-L1 preadipocytes","volume":"6","author":"Lin","year":"1992","journal-title":"Genes Dev."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0245","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/cc.11.4.19125","article-title":"Apoa1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (Ho-1) and Wnt10b","volume":"11","author":"Vanella","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/scrt176","article-title":"Increased heme-oxygenase 1 expression decreases adipocyte differentiation and lipid accumulation in mesenchymal stem cells via upregulation of the canonical wnt signaling cascade","volume":"4","author":"Vanella","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0255","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00244.2004","article-title":"Mest\/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size","volume":"288","author":"Takahashi","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0260","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2011.07.005","article-title":"Crosstalk between Eet and Ho-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes","volume":"96","author":"Vanella","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0265","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/scd.2010.0098","article-title":"Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of Ho-1-Pakt signaling and a decrease in ppargamma","volume":"19","author":"Kim","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0270","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.114.03884","article-title":"Cyp2j2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype","volume":"64","author":"Abraham","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"Pparalpha is a key regulator of hepatic Fgf21","volume":"360","author":"Lundasen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0280","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.2337\/db07-0185","article-title":"Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects","volume":"56","author":"Basu","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0285","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0290","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0295","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2337\/db08-1750","article-title":"Systemic fate of the adipocyte-derived factor adiponectin","volume":"58","author":"Halberg","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0300","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1172\/JCI31021","article-title":"Obesity-associated improvements in metabolic profile through expansion of adipose tissue","volume":"117","author":"Kim","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0305","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.freeradbiomed.2013.02.004","article-title":"High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair","volume":"60","author":"Pan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0310","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M800607-JLR200","article-title":"Hdl is the major lipoprotein carrier of plasma F2-isoprostanes","volume":"50","author":"Proudfoot","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0315","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcm.2005.06.004","article-title":"Formation of dysfunctional high-density lipoprotein by myeloperoxidase","volume":"15","author":"Nicholls","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5414\/CN107639","article-title":"Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis","volume":"80","author":"Puchades","year":"2013","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0325","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","article-title":"Isoprostanes: markers and mediators of oxidative stress","volume":"18","author":"Montuschi","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0330","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/092986707780059607","article-title":"Insights into oxidative stress: the isoprostanes","volume":"14","author":"Montuschi","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"Suppl","key":"10.1016\/j.prostaglandins.2016.04.004_bib0335","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1194\/jlr.R800036-JLR200","article-title":"The role of dysfunctional Hdl in atherosclerosis","volume":"50","author":"Navab","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0340","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","article-title":"The paradox of dysfunctional high-density lipoprotein","volume":"18","author":"Ansell","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0345","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.amjcard.2013.07.045","article-title":"Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins","volume":"112","author":"Kim","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0350","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1253\/circj.CJ-11-0460","article-title":"Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins","volume":"75","author":"Imaizumi","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02693941","article-title":"Modifying the anti-Inflammatory effects of high-density lipoprotein","volume":"9","author":"Ansell","year":"2007","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0360","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00041433-200208000-00003","article-title":"Oxidized lipids as mediators of coronary heart disease","volume":"13","author":"Navab","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0365","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.ATV.0000033829.14012.18","article-title":"Oxidized Ldl in carotid plaques and plasma associates with plaque instability","volume":"22","author":"Nishi","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0370","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","article-title":"Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes","volume":"103","author":"Ehara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0375","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","article-title":"Oxidized Ldl and malondialdehyde-modified Ldl in patients with acute coronary syndromes and stable coronary artery disease","volume":"98","author":"Holvoet","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0380","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0021-9150(00)00573-6","article-title":"Oxidized ldl and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized Ldl with statin therapy","volume":"155","author":"Vasankari","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0385","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbalip.2011.11.011","article-title":"Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by Abca1, a key cardioprotective function of Hdl","volume":"1821","author":"Shao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0390","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2005.05.020","article-title":"Plasma levels of oxidized-low-density lipoproteins are higher In patients with unstable angina and correlated with angiographic coronary complex plaques","volume":"185","author":"Anselmi","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0395","doi-asserted-by":"crossref","first-page":"980547","DOI":"10.1155\/2014\/980547","article-title":"Ho-1 upregulation attenuates adipocyte dysfunction, obesity, and isoprostane levels in mice fed high fructose diets","volume":"2014","author":"Khitan","year":"2014","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.prostaglandins.2016.04.004_bib0400","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/HYPERTENSIONAHA.112.193805","article-title":"Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet","volume":"60","author":"Cao","year":"2012","journal-title":"Hypertension"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T20:26:13Z","timestamp":1655843173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882316300119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":80,"alternative-id":["S1098882316300119"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.04.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}